Cargando…
3D transesophageal echocardiography is a decision-making tool for the management of cardiogenic shock following a large postinfarction ventricular defect
Postinfarction ventricular septal defect (PIVSD) is a devastating mechanical complication following acute myocardial infarction. The management of this pathology is quite challenging, especially in case of complicated cardiogenic shock. The difficulties lie in the timing and type of intervention. De...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312472/ https://www.ncbi.nlm.nih.gov/pubmed/25603876 http://dx.doi.org/10.1186/s13019-015-0208-y |
_version_ | 1782355127248617472 |
---|---|
author | Liu, Yihua Frikha, Zied Maureira, Pablo Levy, Bruno Selton-Suty, Christine Villemot, Jean-pierre Huttin, Olivier |
author_facet | Liu, Yihua Frikha, Zied Maureira, Pablo Levy, Bruno Selton-Suty, Christine Villemot, Jean-pierre Huttin, Olivier |
author_sort | Liu, Yihua |
collection | PubMed |
description | Postinfarction ventricular septal defect (PIVSD) is a devastating mechanical complication following acute myocardial infarction. The management of this pathology is quite challenging, especially in case of complicated cardiogenic shock. The difficulties lie in the timing and type of intervention. Debates exist with regard to immediate versus deferring repair, as well as open repair versus percutaneous closure. The anatomic characteristics and hemodynamic consequence of PIVSD are important elements determining which strategy to adopt, since large septal defect (>15 mm) cannot be appropriately treated by percutaneous occluder devices limiting by their available size, while compromised hemodynamics usually require emergent repair or mechanical support “bridging to surgery”. Herein, we report our experience of successful management of a case of cardiogenic shock complicating large PIVSD (38 mm) by delayed surgical repair bridged with Extracorporeal Membrane Oxygenation (ECMO) during 7 days. We emphasize the importance of 3-dimensional transesophageal echocardiography as a decision-making tool. |
format | Online Article Text |
id | pubmed-4312472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43124722015-02-01 3D transesophageal echocardiography is a decision-making tool for the management of cardiogenic shock following a large postinfarction ventricular defect Liu, Yihua Frikha, Zied Maureira, Pablo Levy, Bruno Selton-Suty, Christine Villemot, Jean-pierre Huttin, Olivier J Cardiothorac Surg Case Report Postinfarction ventricular septal defect (PIVSD) is a devastating mechanical complication following acute myocardial infarction. The management of this pathology is quite challenging, especially in case of complicated cardiogenic shock. The difficulties lie in the timing and type of intervention. Debates exist with regard to immediate versus deferring repair, as well as open repair versus percutaneous closure. The anatomic characteristics and hemodynamic consequence of PIVSD are important elements determining which strategy to adopt, since large septal defect (>15 mm) cannot be appropriately treated by percutaneous occluder devices limiting by their available size, while compromised hemodynamics usually require emergent repair or mechanical support “bridging to surgery”. Herein, we report our experience of successful management of a case of cardiogenic shock complicating large PIVSD (38 mm) by delayed surgical repair bridged with Extracorporeal Membrane Oxygenation (ECMO) during 7 days. We emphasize the importance of 3-dimensional transesophageal echocardiography as a decision-making tool. BioMed Central 2015-01-21 /pmc/articles/PMC4312472/ /pubmed/25603876 http://dx.doi.org/10.1186/s13019-015-0208-y Text en © Liu et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Liu, Yihua Frikha, Zied Maureira, Pablo Levy, Bruno Selton-Suty, Christine Villemot, Jean-pierre Huttin, Olivier 3D transesophageal echocardiography is a decision-making tool for the management of cardiogenic shock following a large postinfarction ventricular defect |
title | 3D transesophageal echocardiography is a decision-making tool for the management of cardiogenic shock following a large postinfarction ventricular defect |
title_full | 3D transesophageal echocardiography is a decision-making tool for the management of cardiogenic shock following a large postinfarction ventricular defect |
title_fullStr | 3D transesophageal echocardiography is a decision-making tool for the management of cardiogenic shock following a large postinfarction ventricular defect |
title_full_unstemmed | 3D transesophageal echocardiography is a decision-making tool for the management of cardiogenic shock following a large postinfarction ventricular defect |
title_short | 3D transesophageal echocardiography is a decision-making tool for the management of cardiogenic shock following a large postinfarction ventricular defect |
title_sort | 3d transesophageal echocardiography is a decision-making tool for the management of cardiogenic shock following a large postinfarction ventricular defect |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312472/ https://www.ncbi.nlm.nih.gov/pubmed/25603876 http://dx.doi.org/10.1186/s13019-015-0208-y |
work_keys_str_mv | AT liuyihua 3dtransesophagealechocardiographyisadecisionmakingtoolforthemanagementofcardiogenicshockfollowingalargepostinfarctionventriculardefect AT frikhazied 3dtransesophagealechocardiographyisadecisionmakingtoolforthemanagementofcardiogenicshockfollowingalargepostinfarctionventriculardefect AT maureirapablo 3dtransesophagealechocardiographyisadecisionmakingtoolforthemanagementofcardiogenicshockfollowingalargepostinfarctionventriculardefect AT levybruno 3dtransesophagealechocardiographyisadecisionmakingtoolforthemanagementofcardiogenicshockfollowingalargepostinfarctionventriculardefect AT seltonsutychristine 3dtransesophagealechocardiographyisadecisionmakingtoolforthemanagementofcardiogenicshockfollowingalargepostinfarctionventriculardefect AT villemotjeanpierre 3dtransesophagealechocardiographyisadecisionmakingtoolforthemanagementofcardiogenicshockfollowingalargepostinfarctionventriculardefect AT huttinolivier 3dtransesophagealechocardiographyisadecisionmakingtoolforthemanagementofcardiogenicshockfollowingalargepostinfarctionventriculardefect |